The DOI matches its Crossref record; 83 of the 83 references it cites were found in a registry or an index.
Technological advancements in cancer diagnostics: Improvements and limitations
Open accessAbstract
Background: Cancer is characterized by the rampant proliferation, growth, and infiltration of malignantly transformed cancer cells past their normal boundaries into adjacent tissues. It is the leading cause of death worldwide, responsible for approximately 19.3 million new diagnoses and 10 million deaths globally in 2020. In the United States alone, the estimated number of new diagnoses and deaths is 1.9 million and 609 360, respectively. Implementation of currently existing cancer diagnostic techniques such as positron emission tomography (PET), X‐ray computed tomography (CT), and magnetic resonance spectroscopy (MRS), and molecular diagnostic techniques, have enabled early detection rates and are instrumental not only for the therapeutic management of cancer patients, but also for early detection of the cancer itself. The effectiveness of these cancer screening programs are heavily dependent on the rate of accurate precursor lesion identification; an increased rate of identification allows for earlier onset treatment, thus decreasing the incidence of invasive cancer in the long‐term, and improving the overall prognosis. Although these diagnostic techniques are advantageous due to lack of invasiveness and easier accessibility within the clinical setting, several limitations such as optimal target definition, high signal to background ratio and associated artifacts hinder the accurate diagnosis of specific types of deep‐seated tumors, besides associated high cost. In this review we discuss various imaging, molecular, and low‐cost diagnostic tools and related technological advancements, to provide a better understanding of cancer diagnostics, unraveling new opportunities for effective management of cancer, particularly in low‐ and middle‐income countries (LMICs). Recent Findings: Herein we discuss various technological advancements that are being utilized to construct an assortment of new diagnostic techniques that incorporate hardware, image reconstruction software, imaging devices, biomarkers, and even artificial intelligence algorithms, thereby providing a reliable diagnosis and analysis of the tumor. Also, we provide a brief account of alternative low cost‐effective cancer therapy devices (CryoPop®, LumaGEM®, MarginProbe®) and picture archiving and communication systems (PACS), emphasizing the need for multi‐disciplinary collaboration among radiologists, pathologists, and other involved specialties for improving cancer diagnostics. Conclusion: Revolutionary technological advancements in cancer imaging and molecular biology techniques are indispensable for the accurate diagnosis and prognosis of cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sung, H., Ferlay, J., Siegel, R. L., Laversanne, M., Soerjomataram, I., Jemal, A., & Bray, F. (2021) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21660 · Cited by 108,699
The emerging role of lncRNAs in cancer
Huarte, M. (2015) · Nature Medicine · doi:10.1038/nm.3981 · Cited by 2,702
Artificial intelligence in cancer imaging: Clinical challenges and applications
Bi, W. L., Hosny, A., Schabath, M. B., Giger, M. L., Birkbak, N. J., Mehrtash, A., Allison, T., Arnaout, O., Abbosh, C., Dunn, I. F., et al. (2019) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21552 · Cited by 1,846
Multicolor Spectral Karyotyping of Human Chromosomes
Schröck, E., du Manoir, S., Veldman, T., Schoell, B., Wienberg, J., Ferguson-Smith, M. A., Ning, Y., Ledbetter, D. H., Bar-Am, I., Soenksen, D., et al. (1996) · Science · doi:10.1126/science.273.5274.494 · Cited by 1,755
Molecular imaging of cancer with positron emission tomography
Gambhir, S. S. (2002) · Nature Reviews Cancer · doi:10.1038/nrc882 · Cited by 1,656
Karyotyping human chromosomes by combinatorial multi-fluor FISH
Speicher, M. R., Ballard, S. G., & Ward, D. C. (1996) · Nature Genetics · doi:10.1038/ng0496-368 · Cited by 1,270
Magnetic resonance imaging of pH in vivo using hyperpolarized 13C-labelled bicarbonate
Gallagher, F. A., Kettunen, M. I., Day, S. E., Hu, D.-E., Ardenkjær-Larsen, J. H., Zandt, R. I. ‘., Jensen, P. R., Karlsson, M., Golman, K., Lerche, M. H., et al. (2008) · Nature · doi:10.1038/nature07017 · Cited by 849
Fass, L. (2008) · Molecular Oncology · doi:10.1016/j.molonc.2008.04.001 · Cited by 822
New Technologies for Human Cancer Imaging
Frangioni, J. V. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.14.3065 · Cited by 800
First Human Imaging Studies with the EXPLORER Total-Body PET Scanner*
Badawi, R. D., Shi, H., Hu, P., Chen, S., Xu, T., Price, P. M., Ding, Y., Spencer, B. A., Nardo, L., Liu, W., et al. (2019) · Journal of Nuclear Medicine · doi:10.2967/jnumed.119.226498 · Cited by 722
Christensen, E., Birkenkamp-Demtröder, K., Sethi, H., Shchegrova, S., Salari, R., Nordentoft, I., Wu, H.-T., Knudsen, M., Lamy, P., Lindskrog, S. V., et al. (2019) · Journal of Clinical Oncology · doi:10.1200/jco.18.02052 · Cited by 556
Cervical cancer in low and middle‑income countries (Review)
Hull, R., Mbele, M., Makhafola, T., Hicks, C., Wang, S., Reis, R., Mehrotra, R., Mkhize‑Kwitshana, Z., Kibiki, G., Bates, D., et al. (2020) · Oncology Letters · doi:10.3892/ol.2020.11754 · Cited by 544
Personalized Detection of Circulating Tumor DNA Antedates Breast Cancer Metastatic Recurrence
Coombes, R. C., Page, K., Salari, R., Hastings, R. K., Armstrong, A., Ahmed, S., Ali, S., Cleator, S., Kenny, L., Stebbing, J., et al. (2019) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-18-3663 · Cited by 510
Next-Generation Sequencing in Oncology: Genetic Diagnosis, Risk Prediction and Cancer Classification
Kamps, R., Brandão, R., Bosch, B., Paulussen, A., Xanthoulea, S., Blok, M., & Romano, A. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18020308 · Cited by 453
Tumor Heterogeneity and Lesion-Specific Response to Targeted Therapy in Colorectal Cancer
Russo, M., Siravegna, G., Blaszkowsky, L. S., Corti, G., Crisafulli, G., Ahronian, L. G., Mussolin, B., Kwak, E. L., Buscarino, M., Lazzari, L., et al. (2016) · Cancer Discovery · doi:10.1158/2159-8290.cd-15-1283 · Cited by 405
Vaquero, J. J., & Kinahan, P. (2015) · Annual Review of Biomedical Engineering · doi:10.1146/annurev-bioeng-071114-040723 · Cited by 383
Cancer Control in Low- and Middle-Income Countries: Is It Time to Consider Screening?
Shah, S. C., Kayamba, V., Peek, R. M., & Heimburger, D. (2019) · Journal of Global Oncology · doi:10.1200/jgo.18.00200 · Cited by 382
Hillner, B. E., Siegel, B. A., Liu, D., Shields, A. F., Gareen, I. F., Hanna, L., Stine, S. H., & Coleman, R. E. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.14.5631 · Cited by 374
Exosomes in Cancer Diagnostics
Soung, Y., Ford, S., Zhang, V., & Chung, J. (2017) · Cancers · doi:10.3390/cancers9010008 · Cited by 368
Application of Nanotechnology in Cancer Diagnosis and Therapy - A Mini-Review
Jin, C., Wang, K., Oppong-Gyebi, A., & Hu, J. (2020) · International Journal of Medical Sciences · doi:10.7150/ijms.49801 · Cited by 353
Imaging tumour hypoxia with positron emission tomography
Fleming, I. N., Manavaki, R., Blower, P. J., West, C., Williams, K. J., Harris, A. L., Domarkas, J., Lord, S., Baldry, C., & Gilbert, F. J. (2015) · British Journal of Cancer · doi:10.1038/bjc.2014.610 · Cited by 330
Applications of immunohistochemistry
Duraiyan, J., Govindarajan, R., Kaliyappan, K., & Palanisamy, M. (2012) · Journal of Pharmacy and Bioallied Sciences · doi:10.4103/0975-7406.100281 · Cited by 239
Use of Pet/Ct Scanning in Cancer Patients: Technical and Practical Considerations
Griffeth, L. K. (2005) · Baylor University Medical Center Proceedings · doi:10.1080/08998280.2005.11928089 · Cited by 237
Extracellular Vesicles – Biomarkers and Effectors of the Cellular Interactome in Cancer
Rak, J. (2013) · Frontiers in Pharmacology · doi:10.3389/fphar.2013.00021 · Cited by 215
MR Spectroscopy and Spectroscopic Imaging of the Brain
Zhu, H., & Barker, P. B. (2011) · Methods in Molecular Biology · doi:10.1007/978-1-61737-992-5_9 · Cited by 208
Next-generation sequencing: advances and applications in cancer diagnosis
Serratì, S., De Summa, S., Pilato, B., Petriella, D., Lacalamita, R., Tommasi, S., & Pinto, R. (2016) · OncoTargets and Therapy · doi:10.2147/ott.s99807 · Cited by 208
A standardized framework for the validation and verification of clinical molecular genetic tests
for the EuroGentest Validation Group, Mattocks, C. J., Morris, M. A., Matthijs, G., Swinnen, E., Corveleyn, A., Dequeker, E., Müller, C. R., Pratt, V., & Wallace, A. (2010) · European Journal of Human Genetics · doi:10.1038/ejhg.2010.101 · Cited by 205
Tanke, H., Wiegant, J., van Gijlswijk, R., Bezrookove, V, Pattenier, H., Heetebrij, R., Talman, E., Raap, A., & Vrolijk, J. (1999) · European Journal of Human Genetics · doi:10.1038/sj.ejhg.5200265 · Cited by 200
Circulating cell-free DNA for cancer early detection
Gao, Q., Zeng, Q., Wang, Z., Li, C., Xu, Y., Cui, P., Xin, Z., Lu, H., Wang, G., Cai, S., et al. (2022) · The Innovation · doi:10.1016/j.xinn.2022.100259 · Cited by 197
Positron emission tomography: An overview
Shukla, A., & Kumar, U. (2006) · Journal of Medical Physics · doi:10.4103/0971-6203.25665 · Cited by 190
Jia, Z., Patra, A., Kutty, V. K., & Venkatesan, T. (2019) · Metabolites · doi:10.3390/metabo9030052 · Cited by 187
Recent Advances and Future Progress in PET Instrumentation
Slomka, P. J., Pan, T., & Germano, G. (2016) · Seminars in Nuclear Medicine · doi:10.1053/j.semnuclmed.2015.09.006 · Cited by 177
Xue, P., Ng, M. T. A., & Qiao, Y. (2020) · BMC Medicine · doi:10.1186/s12916-020-01613-x · Cited by 176
Hybrid Imaging by SPECT/CT and PET/CT: Proven Outcomes in Cancer Imaging
Bockisch, A., Freudenberg, L. S., Schmidt, D., & Kuwert, T. (2009) · Seminars in Nuclear Medicine · doi:10.1053/j.semnuclmed.2009.03.003 · Cited by 169
Ohira, M., Oba, S., Nakamura, Y., Isogai, E., Kaneko, S., Nakagawa, A., Hirata, T., Kubo, H., Goto, T., Yamada, S., et al. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.03.019 · Cited by 155
Recent advances of PET imaging in clinical radiation oncology
Unterrainer, M., Eze, C., Ilhan, H., Marschner, S. N., Roengvoraphoj, O., Schmidt-Hegemann, N.-S., Walter, F., Kunz, W. G., af Rosenschöld, P. M., Jeraj, R., et al. (2020) · Radiation Oncology · doi:10.1186/s13014-020-01519-1 · Cited by 146
Multimodal imaging for improved diagnosis and treatment of cancers
Tempany, C. M., Jayender, J., Kapur, T., Bueno, R., Golby, A. J., Agar, N. Y. R., & Jolesz, F. A. (2014) · Cancer · doi:10.1002/cncr.29012 · Cited by 142
Magnetic resonance image–guided proteomics of human glioblastoma multiforme
Hobbs, S. K., Shi, G., Homer, R., Harsh, G., Atlas, S. W., & Bednarski, M. D. (2003) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.10395 · Cited by 139
Hay Burgess, D. C., Wasserman, J., & Dahl, C. A. (2006) · Nature · doi:10.1038/nature05440 · Cited by 139
Innovations in Instrumentation for Positron Emission Tomography
Berg, E., & Cherry, S. R. (2018) · Seminars in Nuclear Medicine · doi:10.1053/j.semnuclmed.2018.02.006 · Cited by 138
Next generation sequencing in cancer research and clinical application
Shyr, D., & Liu, Q. (2013) · Biological Procedures Online · doi:10.1186/1480-9222-15-4 · Cited by 130
Magnetic resonance spectroscopy — Revisiting the biochemical and molecular milieu of brain tumors
Verma, A. K., Kumar, I., Verma, N., et al. (2016) · BBA Clinical · doi:10.1016/j.bbacli.2016.04.002 · Cited by 119
Self-citationPhoto-Detectors for Time of Flight Positron Emission Tomography (ToF-PET)
Spanoudaki, V. C., & Levin, C. S. (2010) · Sensors · doi:10.3390/s101110484 · Cited by 116
Zhang, Y., Yang, H., An, X., Wang, Z., Yang, X., Yu, M., Zhang, R., Sun, Z., & Wang, Q. (2020) · Small · doi:10.1002/smll.202001003 · Cited by 116
Tettero, J. M., Freeman, S. D., Buecklein, V., Venditti, A., Maurillo, L., Kern, W., Walter, R. B., Wood, B. L., Roumier, C., Philippé, J., et al. (2021) · HemaSphere · doi:10.1097/hs9.0000000000000676 · Cited by 112
Kasi, P. M., Fehringer, G., Taniguchi, H., Starling, N., Nakamura, Y., Kotani, D., Powles, T. B., Li, B. T., Pusztai, L., Aushev, V. N., et al. (2022) · JCO Precision Oncology · doi:10.1200/po.21.00181 · Cited by 111
Jadvar, H., Colletti, P. M., Bolton, R. C. D., Esposito, G., Krause, B. J., Iagaru, A. H., Nadel, H. R., Quinn, D. I., ROHREN, E. M., Subramaniam, R. M., et al. (2017) · Journal of Nuclear Medicine · doi:10.2967/jnumed.117.197988 · Cited by 110
Deep learning techniques for cancer classification using microarray gene expression data
Gupta, S., Gupta, M. K., Shabaz, M., & Sharma, A. K. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2022.952709 · Cited by 110
Molecular magnetic resonance imaging in cancer
Haris, M., Yadav, S. K., Rizwan, A., Singh, A. K., Wang, E., Hariharan, H., Reddy, R. D., & Marincola, F. M. (2015) · Journal of Translational Medicine · doi:10.1186/s12967-015-0659-x · Cited by 109
Molecular Imaging of Apoptosis: From Micro to Macro
Zeng, W., Wang, X., Xu, P., Liu, G., Eden, H. S., & Chen, X. S. (2015) · Theranostics · doi:10.7150/thno.11548 · Cited by 109
Leskinen-Kallio, S., Någren, K., Lehikoinen, P., Ruotsalainen, U., & Joensuu, H. (1991) · British Journal of Cancer · doi:10.1038/bjc.1991.475 · Cited by 108
Microarray cancer feature selection: Review, challenges and research directions
Hambali, M. A., Oladele, T. O., & Adewole, K. S. (2020) · International Journal of Cognitive Computing in Engineering · doi:10.1016/j.ijcce.2020.11.001 · Cited by 107
Duclos, V., Iep, A., Gomez, L., Goldfarb, L., & Besson, F. L. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22084159 · Cited by 100
Miele, E., Spinelli, G. P., Tomao, F., Zullo, A., de Marinis, F., Pasciuti, G., Rossi, L., Zoratto, F., & Tomao, F. (2008) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/1756-9966-27-52 · Cited by 88
Cancer nanomedicine: focus on recent developments and self-assembled peptide nanocarriers
Raza, F., Zafar, H., You, X., Asifullah, K., Wu, J., & Ge, L. (2019) · Journal of Materials Chemistry B · doi:10.1039/c9tb01842e · Cited by 85
Computers in imaging and health care: Now and in the future
Arenson, R. L., Andriole, K. P., Avrin, D. E., & Gould, R. G. (2000) · Journal of Imaging Informatics in Medicine · doi:10.1007/bf03168389 · Cited by 77
Molecular diagnostics and personalized medicine in oncology: Challenges and opportunities
Normanno, N., Rachiglio, A. M., Roma, C., Fenizia, F., Esposito, C., Pasquale, R., Porta, M. L. L., Iannaccone, A., Micheli, F., Santangelo, M. L., et al. (2012) · Journal of Cellular Biochemistry · doi:10.1002/jcb.24401 · Cited by 68
Hypoxia imaging and radiotherapy: bridging the resolution gap
Grimes, D. R., Warren, D., & Warren, S. (2017) · British Journal of Radiology · doi:10.1259/bjr.20160939 · Cited by 68
Cervical Precancer Treatment in Low- and Middle-Income Countries: A Technology Overview
Maza, M., Schocken, C., Bergman, K. L., Randall, T. C., & Cremer, M. (2016) · Journal of Global Oncology · doi:10.1200/jgo.2016.003731 · Cited by 64
Zugni, F., Padhani, A. R., Koh, D., Summers, P. E., Bellomi, M., & Petralia, G. (2020) · Cancer Imaging · doi:10.1186/s40644-020-00315-0 · Cited by 64
Ji, T., Zhao, Y., Wang, J., Zheng, X., Tian, Y., Zhao, Y., & Nie, G. (2013) · Small · doi:10.1002/smll.201300600 · Cited by 62
Booij, R., Budde, R. P. J., Dijkshoorn, M. L., & van Straten, M. (2020) · European Journal of Radiology · doi:10.1016/j.ejrad.2020.109261 · Cited by 62
Medina‐Lara, A., Grigore, B., Lewis, R. A., Peters, J., Price, S., Landa, P., Robinson, S., Neal, R. D., Hamilton, W. T., & Spencer, A. E. (2020) · Health Technology Assessment · doi:10.3310/hta24660 · Cited by 53
Carbon ions beam therapy monitoring with the INSIDE in-beam PET
Pennazio, F., Battistoni, G., Bisogni, M. G., Camarlinghi, N., FERRARI, A., Ferrero, V., Fiorina, E., Morrocchi, M., SALA, P. R., Sportelli, G., et al. (2018) · Physics in Medicine and Biology · doi:10.1088/1361-6560/aacab8 · Cited by 50
Multimodality Imaging in Tumor Angiogenesis: Present Status and Perspectives
Asabella, A. N., Palo, A. D., Altini, C., Ferrari, C., & Rubini, G. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18091864 · Cited by 45
Role of Molecular Biology in Cancer Treatment: A Review Article.
Imran, A., Qamar, H. Y., Ali, Q., Naeem, H., Riaz, M., Amin, S., Kanwal, N., Ali, F., Sabar, M. F., & Nasir, I. A. (2017) · PubMed Central · Cited by 43
Walter, W., Pfarr, N., Meggendorfer, M., Jost, P. J., Haferlach, T., & Weichert, W. (2020) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2020.10.015 · Cited by 35
Radionuclide-Based Imaging of Breast Cancer: State of the Art
Li, H., Liu, Z., Yuan, L., Fan, K. S., Zhang, Y., Cai, W., & Lan, X. (2021) · Cancers · doi:10.3390/cancers13215459 · Cited by 34
Cancer diagnostics: current concepts and future perspectives
Montagnana, M., & Lippi, G. (2017) · Annals of Translational Medicine · doi:10.21037/atm.2017.06.20 · Cited by 33
Zimmer-Stelmach, A., Zak, J., Pawłosek, A., Rosner‐Tenerowicz, A., Budny-Wińska, J., Pomorski, M., Fuchs, T., & Zimmer, M. (2022) · Diagnostics · doi:10.3390/diagnostics12010106 · Cited by 33
Fici, P. (2018) · Methods in molecular biology · doi:10.1007/978-1-4939-8973-7_4 · Cited by 32
Pearlman, P. C., Divi, R. L., Gwede, M., Tandon, P., Sorg, B. S., Ossandon, M. R., Agrawal, L., Pai, V. M., Baker, H., & Lash, T. B. (2016) · IEEE Journal of Translational Engineering in Health and Medicine · doi:10.1109/jtehm.2016.2604485 · Cited by 30
Mrs-based Metabolomics in Cancer Research
Bezabeh, T., Ijare, O. B., Nikulin, A. E., Somorjai, R. L., & Smith, I. C. P. (2014) · Magnetic Resonance Insights · doi:10.4137/mri.s13755 · Cited by 25
Zhou, Y., Han, Z., Dou, F., & Yan, T. (2021) · World Journal of Surgical Oncology · doi:10.1186/s12957-021-02215-4 · Cited by 25
Current potential and limitations of molecular diagnostic methods in head and neck cancer
Mahfouz, M. E., Rodrigo, J. P., Takes, R. P., Elsheikh, M. N., Rinaldo, A., Brakenhoff, R. H., & Ferlito, A. (2009) · European Archives of Oto-Rhino-Laryngology · doi:10.1007/s00405-009-1177-3 · Cited by 22
Valvert, F., Silva, O., Solórzano, E., Puligandla, M., Tala, M. M. S., Guyon, T., Dixon, S. L., López, N., López, F., Alvarado, C. C. C., et al. (2021) · Blood Advances · doi:10.1182/bloodadvances.2021004347 · Cited by 22
A Nomogram Modeling 11C-MET PET/CT and Clinical Features in Glioma Helps Predict IDH Mutation
Zhou, W., Zhou, Z., Wen, J., Xie, F., Zhu, Y., Zhang, Z., Xiao, J., Chen, Y., Li, M., Guan, Y., et al. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.01200 · Cited by 19
Current and future challenges in quality assurance in molecular diagnostics
Ahmad‐Nejad, P., Ashavaid, T. F., Salinas, A. V., Huggett, J. F., Harris, K., Linder, M. W., Baluchova, K., Steimer, W., & Payne, D. A. (2021) · Clinica Chimica Acta · doi:10.1016/j.cca.2021.05.004 · Cited by 19
Patel, V., Papineni, R. V. L., Gupta, S., Stoyanova, R. S., & Ahmed, M. M. (2012) · Radiation Research · doi:10.1667/rr2597.1 · Cited by 17
Self-citationPET-Specific Parameters and Radiotracers in Theoretical Tumour Modelling
Jennings, M., Marcu, L. G., & Bezak, E. (2015) · Computational and Mathematical Methods in Medicine · doi:10.1155/2015/415923 · Cited by 13
Ahmad, E., Ali, A., Nimisha, Sharma, A. K., Apurva, A., Kumar, A., Dar, G. M., Sattar, R. S. A., Verma, R., Mahajan, B., et al. (2022) · Clinica Chimica Acta · doi:10.1016/j.cca.2022.05.029 · Cited by 11
Nnaji, C. A., Kuodi, P., Walter, F. M., et al. (2021) · BMJ Open · doi:10.1136/bmjopen-2020-044093 · Cited by 9
FISH, CGH, and SKY in the Diagnosis of Childhood Acute Lymphoblastic Leukemia
Mathew, S., & Raimondi, S. C. (2003) · Humana Press eBooks · doi:10.1385/1-59259-363-1:213 · Cited by 8
Cited by
Nanoparticles in cancer theragnostic and drug delivery: A comprehensive review
Al-Thani, A. N., Jan, A. G., Abbas, M., Geetha, M., & Sadasivuni, K. K. (2024) · Life Sciences · doi:10.1016/j.lfs.2024.122899 · Cited by 323
Sabit, H., Pawlik, T. M., Radwan, F., Abdel-Hakeem, M., Abdel-Ghany, S., Wadan, A.-H. S., Elzawahri, M., El-Hashash, A., & Arneth, B. (2025) · Molecular Cancer · doi:10.1186/s12943-025-02357-z · Cited by 239
Metadata
- Authors
- Pulumati, A., Pulumati, A., Dwarakanath, B. S., Verma, A., & Papineni, R. V. L.
- Venue
- Cancer Reports
- Publisher
- Wiley
- Published
- 2023-01-06
- Volume
- 6
- Issue
- 2
- Pages
- e1764-e1764
- ISSN
- 2573-8348 (ISSN-L)
- OpenAlex
- W4313650905
- Cited by
- 326
- References
- 83
- FWCI
- 48.12
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.